For people with type 2 diabetes, lowering their blood sugar by 1% using certain diabetes medications is linked to a 25% lower chance of having a heart attack, stroke, or dying from heart disease.

48

Pro

0

Against

Evidence from Studies

Supporting (1)

48

Community contributions welcome

48

Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials

Systematic Review With Meta-Analysis

Human

2025 Apr

This study found that when people with type 2 diabetes lower their blood sugar by 1% using GLP-1 drugs, they have a 25% lower chance of having a heart attack, stroke, or dying from heart disease — which is exactly what the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials

Score: 48

DOI: 10.1007/s10557-024-07547-3

Similar Assertions

GLP-1 diabetes drugs that lower blood sugar and weight the most tend to offer the biggest protection against heart attacks and strokes in people with type 2 diabetes.

48

0

90%

Losing just 1 kilogram (about 2.2 pounds) of body weight while taking GLP-1 diabetes drugs is linked to a 7% lower chance of having a heart attack, stroke, or dying from heart disease.

48

0

86%

For people with type 2 diabetes, lowering their blood pressure or bad cholesterol with GLP-1 drugs doesn't seem to make a noticeable difference in their risk of heart attack or stroke.

0

48

83%

For people with type 2 diabetes, GLP-1 drugs like semaglutide and dulaglutide lower the chance of having a stroke caused by a blood clot by nearly 1 in 6 — more than any other diabetes medicine.

1

0

77%

Diabetes drugs like semaglutide and liraglutide cut heart attacks, strokes, and kidney failure by up to a third — and they work fast, even before blood sugar drops, likely by calming down harmful inflammation in the body.

1

0

76%